Delivery Order SPE2DR25D3011-SPE2DR26FW36F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,773.70 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This non-competitive, firm fixed-price delivery order was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,968.71 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 29, 2025, with completion expected by December 30, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under the company's existing contract vehicle with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a $3,366.17 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 5, 2025, with completion expected by December 8, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed-price contract valued at $8,420.18. The award, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $36,336.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4MG tablets (30-count supply) on December 17, 2025, with an ultimate completion date of January 15, 2026. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $26,507.76 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 14, 2025, and was awarded on November 13, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $6,713.22. The contract was competitively awarded without set-aside designation and is scheduled for completion by November 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,839.75 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 22, 2025, with an ultimate completion date of December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,338.27 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $27,358.58 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive award, executed on December 5, 2025, represents a firm fixed price delivery order with a completion date of December 8, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3011Indefinite Delivery Contract
- SPE2DR25D3011-SPE2DR26FW36FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,314.29 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order was issued on December 30, 2025, with an ultimate completion date of December 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor contract running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and established federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a critical supplier in the federal medical supply chain, the company maintains an extensive portfolio of pharmaceutical products including generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Ondansetron ODT tablets supplied under this order serve as an antiemetic medication commonly used in military and veteran healthcare settings for nausea and vomiting management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 12/29/25 |